USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$43.47 USD
+0.33 (0.76%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $43.44 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
USNA 43.47 +0.33(0.76%)
Will USNA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USANA Health Sciences (USNA) Q3 Earnings Miss Estimates
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Earnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to Decline
Other News for USNA
Commit To Buy USANA Health Sciences At $22.50, Earn 6% Annualized Using Options
USANA Honored with Local Healthy Worksite Award
RSPS: Consumer Staples Dashboard For April
Small and midcap pair trades for every sector - Oppenheimer
USANA Schedules First Quarter 2024 Earnings Release and Conference Call